Kura Oncology

KURA NASDAQ
19.55
+0.38
+1.98%
盘后: 19.55 0 0.00% 18:07 06/25 EDT
开盘
19.38
昨收
19.17
最高
20.01
最低
19.30
成交量
35.93万
成交均量(3M)
27.18万
52周最高
22.00
52周最低
10.20
换手率
0.80%
市值
8.79亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Kura Oncology KURA股票价格,Kura Oncology股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small molecule product candidates that targets cell-signaling pathways, which drives the progression of certain cancers. It is developing its lead product candidate, tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with tumors that have mutations in or other dysregulation of the mitogen-activated protein kinase (MAPK), signaling pathway, including pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma.
展开 >

最近浏览

名称
价格
涨跌幅